Clinical Trial Update: Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

View source ↗

Summary

Real-world outcome study of rheumatoid arthritis patients in Korea treated with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-03-22